Interview: Bill Doherty – MD, Cook Ireland and EVP of Cook Group Europe,…
Bill Doherty, MD of Cook Ireland and EVP of Cook Group Europe, one of the largest private medical device companies in the world, discusses his main priorities at the moment,…
Address: Novo Nordisk Ireland, 2nd Floor, 2 Hume St. Dublin 2,Ireland
Tel: 1850 665665
Web: http://www.novonordisk.ie/documents/home_page/document/index.asp
General information:
Irish office: 3/4 Upper Pembroke Street, Dublin 2
Global headquarters: Bagsværd, Denmark
Irish workforce: 24 employees
Global workforce: More than 31,300 employees
International production facilities in seven countries
Product areas
Diabetes care
Hormone replacement therapy (HRT)
Haemostasis management
Growth hormone therapy.
Clinical research:
Before any medicine is available for doctors to prescribe, it must be granted a license by the government. Therefore, all medicines have to be tested in appropriate patients to ensure that they reach the standards of safety and efficacy required by governmental agencies around the world. This is achieved by conducting clinical trials in which patients freely volunteer to try new medicines so that relevant data can be obtained. All clinical trials must conform to globally accepted scientific and ethical standards before they can proceed.
Novo Nordisk is committed to ensuring that all its products meet the highest quality standards and are rigorously tested by performing clinical trials in collaboration with doctors and nurses around the world, including sites in Ireland.
Novo Nordisk way:
In 1923, our Danish founders began a journey to change diabetes.
Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes.
Our ambition is to strengthen our leadership in diabetes. Our key contribution is to discover and develop innovative biological medicines and make them accessible to patients throughout the world. We aspire to change possibilities in haemophilia and other serious chronic conditions where we can make a difference. Growing our business and delivering competitive financial results is what allows us to help patients live better lives, offer an attractive return to our shareholders and contribute to our communities.
We never compromise on quality and business ethics
Our business philosophy is one of balancing financial, social and environmental considerations – we call it ‘The Triple Bottom Line’
We are open and honest, ambitious and accountable, and treat everyone with respect
We offer opportunities for our people to realise their potential.
Every day, we must make difficult choices, always keeping in mind, what is best for patients, our employees and our shareholders in the long run.
It’s the Novo Nordisk Way.
Haemophilia and Eating Disorders.
Diabetes Care.
Hormone Replacement Therapy.
Bill Doherty, MD of Cook Ireland and EVP of Cook Group Europe, one of the largest private medical device companies in the world, discusses his main priorities at the moment,…
Donal O’Callaghan, founder and CEO of Callaghan Engineering, an Irish engineering and construction firm, tells us what motivated him to break into the pharma market in 1990, the changes in…
Frederic Secail, General Manager of Servier’s second strategic and international production facility within Servier Industry, located in Arklow, Ireland, outlines his ambitious transformation program, Arklow 2020, to anticipate and prepare…
Shane Ryan, in his first month as Country Lead for Takeda Products Ireland, speaks about his mandate to position Takeda as the leader in IBD and oncology with exciting new…
Dan McAlister and Ramy Michael, two of EIDA Solutions’ cofounders, tell us the exciting story behind EIDA Solutions’ rapid growth to become one of the best intelligent construction software companies…
James Lennertz, Group VP and GM EUMEA for BioMarin, discusses the key highlights of the past few years for BioMarin, their unique positioning as a company offering innovative therapies for…
Donal Higgins, MD of Prochem Engineering, provides an overview of their life sciences operations, the key innovations they are bringing to the industry like computational fluid dynamics (CFD), and his…
Deirdre Bourke, Country Lead at Eli Lilly’s Irish affiliate, highlights the strategic importance of Ireland to Lilly’s global operations, their exciting upcoming pipeline, the challenges and opportunities she foresees for…
Paula O’Neill, co-founder and MD of Premium Power, an Irish electrical consultancy, highlights the importance of having safe, resilient and efficient electrical systems, particularly in high-tech industries like pharmaceutical manufacturing,…
Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it comes into play in Ireland,…
Philip Martin, founder and CEO of Irish E-PPM software provider, Cora Systems, outlines his company’s successful growth in the past two decades, his bold plans for expansion into the US…
Chairman for BioPharmaChemical Ireland and Leader of Pfizer’s two small molecule API manufacturing sites in Cork, Seamus Fives recounts his team’s efforts to avert the closure of the Little Island…
See our Cookie Privacy Policy Here